CAS: 4628-39-1; 2-(2,6-Dioxo-1,2,3,6-Tetrahydropyrimidin-4-yl)Acetic Acid
该化合物是一种环环状有机化合物,其特点是具有湿环状结构,具有四氢结构,表明其含有饱和环状系统,有助于其稳定性和再活性,结构中存在两个碳基组(二氧化物),表明其可能表现出显著的再活动,特别是在核生殖反应中.此外,乙酸酶表明其具有酸性,可影响其溶性以及与其他化学物种的相互作用.该化合物可能因其潜在的生物活动而对医药化学感兴趣,因为其潜在的生物活动,因为经常会探讨丙酰胺衍生物在医药化学中的角色.其物理特性,如熔点,沸点和溶性,将取决于样品的具体条件和纯度.
- 英文名称2-(2,6-Dioxo-1,2,3,6-Tetrahydropyrimidin-4-yl)Acetic Acid
- 中文名称尿嘧啶-4-乙酸
- IUPAC名称2-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)acetic acid
- 其它别名1,2,3,6-Tetrahydro-2,6-Dioxo-4-Pyrimidineaceticaci; 6-Carboxymethyluracil; 1,2,3,6-Tetrahydro-2,6-Dioxo-4-Pyrimidineacetic Acid; 2,4-Dioxo-1,2,3,4-Tetrahydropyrimidine-6-Acetic Acid; 2,6-Dioxo-1,2,3,6-Tetrahydro-4-Pyrimidineacetic Acid; 2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Acetic Acid; 4-Pyrimidineacetic Acid, 1,2,3,6-Tetrahydro-2,6-Dioxo-; Uracil-4-Acetic Acid
- CAS编号4628-39-1
- MFCD编号:MFCD00235023
- EINECS号:863-849-3
- FDA UNII编号:EF762EX2DY
- 分子式:C6H6N2O4分子量:170.12
- 产品CID: 1462124
- 产品分类有机原料→分子砌块→芳杂环类化合物→嘧啶类化合物
相似化合物
6426-84-2 6535-93-9 6426-90-0物理性质
MSDS等安全信息
欧盟法规
C&L通报上下游产品
CAS号77-92-9 柠檬酸 | CAS号65-86-1 乳清酸合成工艺路线路线简述
📜柠檬酸置于硫酸,三氧化硫体系中,化学反应生成 尿嘧啶-4-乙酸
参考文献:Drehmann; Born,Journal Fuer Praktische Chemie (Leipzig),1958,Vol. <4> 5,P. 200,206
标题:Drehmann; Born,Journal Fuer Praktische Chemie (Leipzig),1958,Vol. <4> 5,P. 200,206
海关参考信息
- 2912110000-甲醛
2912120000-乙醛
2915110000-甲酸
2915211900-乙酸 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-8273403-B2
优先权日:2002-05-10
标题 :Generation of surface coating diversity
发明人：BARDEN MICHAEL C; KAMBOURIS PETER A
权利人:BARDEN MICHAEL C; KAMBOURIS PETER A; BIO LAYER PTY LTD
摘要:This invention relates to a surface discovery system and high-throughput combinatorial synthesis methods for generating large numbers of diverse surface coatings on solid substrates. The system is built upon a synthon which comprises at least three elements: a chemical backbone coating on the solid substrate that comprises a copolymer (B) of at least one passive constituent (P) and at least one active constituent (A); a spacer unit (S) separating the backbone from a functional group; and a functional group (F). The methods comprise the following steps: 1) selecting a plurality of synthons so that each synthon has at least two points of diversity selected from P, A, S and F; 2) applying copolymer B onto a substrate; and 3) attaching a combination of S and F to constituent A of copolymer B. Steps 2) and 3) are performed such that different synthons are generated on localized regions of the substrate.
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
合成参考文献
参考文献:10.1016/j.bmcl.2009.11.017
摘要:Roy AC, Lunn FA, Bearne SL. Inhibition of CTP synthase from Escherichia coli by xanthines and uric acids. Bioorganic & Medicinal Chemistry Letters. 2010 Jan;20(1):141–4. doi: 10.1016/j.bmcl.2009.11.017.
摘要:S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749
📝 需求与反馈
尽可能描述清楚需求与问题信息
